Next Generation Sequencing Market

Next Generation Sequencing Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, Technology, Application and End-User: Global Opportunity and Industry Forecast (2025-2030)

Report ID:

1097

Industry:

Healthcare

Published on:

Nov 2025

1. Next Generation Sequencing Market: Overview

1.1. Study Assumption and Market Definition

1.2. Scope of the Study

1.3. Executive Summary

1.3.1. Market Size and Market Share by Segments, Region and Country

2. Next Generation Sequencing Market: Market Variables and Key Insights

2.1. Next Generation Sequencing Market Dynamics

2.1.1. Market Trends Analysis

2.1.2. Market Drivers Analysis

2.1.3. Market Challenges Analysis

2.1.4. Market Opportunities Analysis

2.2. Next Generation Sequencing Market Business Tools Analysis

2.2.1. PORTER’s Five Forces Analysis

2.2.2. PESTLE Analysis

2.3. Technology Roadmap

2.4. Value Chain Analysis

2.5. Regulatory Landscape by Region

1. North America

2. Europe

3. Asia Pacific

4. Middle East and Africa

5. South America

2.6. Analysis of Government Schemes and Initiatives on the Global Next Generation Sequencing Industry

3. Next Generation Sequencing Market: Global Market Size, Trend Analysis and Forecast (2024-2030) in Value (USD Billion)

3.1. Global Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

3.1.1. Instruments

3.1.2. Reagents & Consumables

3.1.3. Services

3.2. Global Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

3.2.1. Whole Genome Sequencing

3.2.2. Targeted Sequencing & Re-sequencing

3.2.3. Whole Exome Sequencing

3.2.4. RNA Sequencing

3.2.5. Chip Sequencing

3.2.6. De Novo Sequencing

3.2.7. Methyl Sequencing

3.3. Global Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

3.3.1. Drug Discovery/Personalized Medicine

3.3.2. Genetic Screening

3.3.3. Diagnostics/Infectious Diseases

3.3.4. Agricultural & Animal Research

3.3.5. Others

3.4. Global Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

3.4.1. Healthcare Institutions

3.4.2. Academics

3.4.3. Biotech & Pharma Firms

3.4.4. Others

3.5. Global Next Generation Sequencing Market Size and Forecast, By Country (2024-2030)

3.5.1. North America

3.5.2. Europe

3.5.3. Asia Pacific

3.5.4. Middle East & Africa

3.5.5. South America

4. Next Generation Sequencing Market: North America Market Size, Trend Analysis and Forecast (2024-2030) in Value (USD Billion)

4.1. North America Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

4.1.1. Instruments

4.1.2. Reagents & Consumables

4.1.3. Services

4.2. North America Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

4.2.1. Whole Genome Sequencing

4.2.2. Targeted Sequencing & Re-sequencing

4.2.3. Whole Exome Sequencing

4.2.4. RNA Sequencing

4.2.5. Chip Sequencing

4.2.6. De Novo Sequencing

4.2.7. Methyl Sequencing

4.3. North America Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

4.3.1. Drug Discovery/Personalized Medicine

4.3.2. Genetic Screening

4.3.3. Diagnostics/Infectious Diseases

4.3.4. Agricultural & Animal Research

4.3.5. Others

4.4. North America Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

4.4.1. Healthcare Institutions

4.4.2. Academics

4.4.3. Biotech & Pharma Firms

4.4.4. Others

4.5. North America Next Generation Sequencing Market Size and Forecast, by Country (2024-2030)

4.5.1. United States

4.5.2. Mexico

4.5.3. Canada

4.5.1.1 United States Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

4.5.1.2 United States Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

4.5.1.3 United States Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

4.5.1.4 United States Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

4.5.2.1 Mexico Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

4.5.2.2 Mexico Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

4.5.2.3 Mexico Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

4.5.2.4 Mexico Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

4.5.3.1 Canada Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

4.5.3.2 Canada Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

4.5.3.3 Canada Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

4.5.3.4 Canada Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5. Next Generation Sequencing Market: Europe Market Size, Trend Analysis and Forecast (2024-2030) in Value (USD Billion)

5.1. Europe Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.1.1. Instruments

5.1.2. Reagents & Consumables

5.1.3. Services

5.2. Europe Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.2.1. Whole Genome Sequencing

5.2.2. Targeted Sequencing & Re-sequencing

5.2.3. Whole Exome Sequencing

5.2.4. RNA Sequencing

5.2.5. Chip Sequencing

5.2.6. De Novo Sequencing

5.2.7. Methyl Sequencing

5.3. Europe Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.3.1. Drug Discovery/Personalized Medicine

5.3.2. Genetic Screening

5.3.3. Diagnostics/Infectious Diseases

5.3.4. Agricultural & Animal Research

5.3.5. Others

5.4. Europe Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.4.1. Healthcare Institutions

5.4.2. Academics

5.4.3. Biotech & Pharma Firms

5.4.4. Others

5.5. Europe Next Generation Sequencing Market Size and Forecast, By Country (2024-2030)

5.5.1. United Kingdom

5.5.2. France

5.5.3. Germany

5.5.4. Italy

5.5.5. Spain

5.5.6. Sweden

5.5.7. Russia

5.5.8. Rest of Europe

5.5.1.1 United Kingdom Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.1.2 United Kingdom Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.1.3 United Kingdom Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.1.4 United Kingdom Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.5.2.1 France Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.2.2 France Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.2.3 France Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.2.4 France Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.5.3.1 Germany Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.3.2 Germany Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.3.3 Germany Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.3.4 Germany Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.5.4.1 Italy Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.4.2 Italy Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.4.3 Italy Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.4.4 Italy Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.5.5.1 Spain Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.5.2 Spain Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.5.3 Spain Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.5.4 Spain Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.5.6.1 Sweden Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.6.2 Sweden Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.6.3 Sweden Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.6.4 Sweden Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.5.7.1 Russia Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.7.2 Russia Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.7.3 Russia Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.7.4 Russia Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

5.5.8.1 Rest of Europe Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

5.5.8.2 Rest of Europe Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

5.5.8.3 Rest of Europe Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

5.5.8.4 Rest of Europe Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6. Next Generation Sequencing Market: Asia Pacific Market Size, Trend Analysis and Forecast (2024-2030) in Value (USD Billion)

6.1. Asia Pacific Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.1.1. Instruments

6.1.2. Reagents & Consumables

6.1.3. Services

6.2. Asia Pacific Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.2.1. Whole Genome Sequencing

6.2.2. Targeted Sequencing & Re-sequencing

6.2.3. Whole Exome Sequencing

6.2.4. RNA Sequencing

6.2.5. Chip Sequencing

6.2.6. De Novo Sequencing

6.2.7. Methyl Sequencing

6.3. Asia Pacific Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.3.1. Drug Discovery/Personalized Medicine

6.3.2. Genetic Screening

6.3.3. Diagnostics/Infectious Diseases

6.3.4. Agricultural & Animal Research

6.3.5. Others

6.4. Asia Pacific Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6.4.1. Healthcare Institutions

6.4.2. Academics

6.4.3. Biotech & Pharma Firms

6.4.4. Others

6.5. Asia Pacific Next Generation Sequencing Market Size and Forecast, By Country (2024-2030)

6.5.1. China

6.5.2. South Korea

6.5.3. Japan

6.5.4. India

6.5.5. Australia

6.5.6. ASEAN

6.5.7. Rest of Asia Pacific

6.5.1.1 China Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.5.1.2 China Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.5.1.3 China Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.5.1.4 China Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6.5.2.1 South Korea Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.5.2.2 South Korea Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.5.2.3 South Korea Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.5.2.4 South Korea Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6.5.3.1 Japan Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.5.3.2 Japan Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.5.3.3 Japan Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.5.3.4 Japan Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6.5.4.1 India Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.5.4.2 India Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.5.4.3 India Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.5.4.4 India Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6.5.5.1 Australia Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.5.5.2 Australia Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.5.5.3 Australia Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.5.5.4 Australia Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6.5.6.1 ASEAN Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.5.6.2 ASEAN Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.5.6.3 ASEAN Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.5.6.4 ASEAN Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

6.5.7.1 Rest of Asia Pacific Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

6.5.7.2 Rest of Asia Pacific Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

6.5.7.3 Rest of Asia Pacific Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

6.5.7.4 Rest of Asia Pacific Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

7. Next Generation Sequencing Market: Middle East & Africa Market Size, Trend Analysis and Forecast (2024-2030) in Value (USD Billion)

7.1. Middle East & Africa Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

7.1.1. Instruments

7.1.2. Reagents & Consumables

7.1.3. Services

7.2. Middle East & Africa Next Generation Sequencing Market Size and Forecast, By Technology

(2024-2030)

7.2.1. Whole Genome Sequencing

7.2.2. Targeted Sequencing & Re-sequencing

7.2.3. Whole Exome Sequencing

7.2.4. RNA Sequencing

7.2.5. Chip Sequencing

7.2.6. De Novo Sequencing

7.2.7. Methyl Sequencing

7.3. Middle East & Africa Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

7.3.1. Drug Discovery/Personalized Medicine

7.3.2. Genetic Screening

7.3.3. Diagnostics/Infectious Diseases

7.3.4. Agricultural & Animal Research

7.3.5. Others

7.4. Middle East & Africa Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

7.4.1. Healthcare Institutions

7.4.2. Academics

7.4.3. Biotech & Pharma Firms

7.4.4. Others

7.5. Middle East & Africa Next Generation Sequencing Market Size and Forecast, by Country (2024-2030)

7.5.1. South Africa

7.5.2. GCC

7.5.3. Turkey

7.5.4. Rest of ME&A

7.5.1.1 South Africa Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

7.5.1.2 South Africa Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

7.5.1.3 South Africa Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

7.5.1.4 South Africa Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

7.5.2.1 GCC Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

7.5.2.2 GCC Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

7.5.2.3 GCC Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

7.5.2.4 GCC Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

7.5.3.1 Turkey Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

7.5.3.2 Turkey Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

7.5.3.3 Turkey Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

7.5.3.4 Turkey Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

7.5.4.1 Rest of ME&A Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

7.5.4.2 Rest of ME&A Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

7.5.4.3 Rest of ME&A Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

7.5.4.4 Rest of ME&A Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

8. Next Generation Sequencing Market: South America Market Size, Trend Analysis and Forecast (2024-2030) in Value (USD Billion)

8.1. South America Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

8.1.1. Instruments

8.1.2. Reagents & Consumables

8.1.3. Services

8.2. South America Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

8.2.1. Whole Genome Sequencing

8.2.2. Targeted Sequencing & Re-sequencing

8.2.3. Whole Exome Sequencing

8.2.4. RNA Sequencing

8.2.5. Chip Sequencing

8.2.6. De Novo Sequencing

8.2.7. Methyl Sequencing

8.3. South America Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

8.3.1. Drug Discovery/Personalized Medicine

8.3.2. Genetic Screening

8.3.3. Diagnostics/Infectious Diseases

8.3.4. Agricultural & Animal Research

8.3.5. Others

8.4. South America Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

8.4.1. Healthcare Institutions

8.4.2. Academics

8.4.3. Biotech & Pharma Firms

8.4.4. Others

8.5. South America Next Generation Sequencing Market Size and Forecast, by Country (2024-2030)

8.5.1. Brazil

8.5.2. Argentina

8.5.3. Rest of South America

8.5.1.1 Brazil Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

8.5.1.2 Brazil Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

8.5.1.3 Brazil Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

8.5.1.4 Brazil Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

8.5.2.1 Argentina Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

8.5.2.2 Argentina Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

8.5.2.3 Argentina Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

8.5.2.5 Argentina Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

8.5.3.1 Rest of South America Next Generation Sequencing Market Size and Forecast, By Product Type (2024-2030)

8.5.3.2 Rest of South America Next Generation Sequencing Market Size and Forecast, By Technology (2024-2030)

8.5.3.3 Rest of South America Next Generation Sequencing Market Size and Forecast, By Application (2024-2030)

8.5.3.4 Rest of South America Next Generation Sequencing Market Size and Forecast, By End-User (2024-2030)

9. Next Generation Sequencing Market: Competitive Landscape

9.1. JBI Competition Matrix

9.2. Competitive Landscape

9.3. Key Players Benchmarking

1. Company Name

2. Product Segment

3. End-User Segment

4. Revenue Details

5. Market Share

6. Company Locations

9.4. Market Categorisation

1. Market Leaders

2. Market Followers

3. Market Emerging Players

4. Mergers and Acquisitions Details

9.5. Company Profiles of Leading Market Players ((Company Overview, Product Portfolio, Financial Overview, SWOT Analysis, Strategies, Recent Developments, (Based on Availability)

1. Company Name

2. Product Segment

3. End-User Segment

4. Revenue Details

5. Market Share

6. Company Locations

9.5.1. Illumina, Inc.

9.5.2. Thermo Fisher Scientific, Inc.

9.5.3. F. Hoffmann-La Roche Ltd. (Roche)

9.5.4. QIAGEN N.V.

9.5.5. Agilent Technologies, Inc.

9.5.6. Pacific Biosciences (PacBio)

9.5.7. Oxford Nanopore Technologies

9.5.8. BGI Genomics / BGI Group

9.5.9. PerkinElmer, Inc.

9.5.10. Eurofins Scientific

9.5.11. Danaher Corporation

9.5.12. Merck KGaA

9.5.13. 10x Genomics

9.5.14. New England Biolabs (NEB)

9.5.15. Novogene Co., Ltd.

10. Next Generation Sequencing Market: Strategic Recommendations

11. Next Generation Sequencing Market: Key Takeaways

12. Next Generation Sequencing Market: Research Methodology

Note:

• The table of contents is as per our syndicate report aimed at a broader audience, can be modified as per requirements.

• TOC can be amended before delivery as per research updates by the analysts.

Next Generation Sequencing Market Summary

Global Next Generation Sequencing Market was a value of USD 10.30 Billion in 2024 and expected to reached at USD 24.07 Billion by 2030, with a CAGR of 15.2 % during the forecast period (2025-2030).

Next Generation Sequencing Industry Trends and Analytical Insights -

North America Next Generation Sequencing Market was the largest revenue generating region market in year 2024, with market share accounted for 45.60 %.
In 2024, By Technology, Targeted Sequencing & Re-sequencing dominated the Next Generation Sequencing Market, accounted for 42.5% market shares.
Leading Key players for Next Generation Sequencing Market in 2024 was Illumina, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd. (Roche), QIAGEN N.V. and Agilent Technologies, Inc.

Market Size & Forecast

Market Size 2024: USD 10.30 Billion
Projected Market Size 2030: USD 24.07 Billion
CAGR (2024-2030): 15.2%
North America: Dominated market in 2024

Next Generation Sequencing Market Overview

The‍‌‍‍‌‍‌‍‍‌ Next Generation Sequencing market in 2024 features a rapidly maturing technology and increasing clinical usage, which was largely a result of more than 1,200 Genomic Research Programs was active globally. The usage had increased significantly in cancer, infectious disease diagnostics, and reproductive genomics, which was a major reason why Next Generation Sequencing Industry platforms can handle billions of DNA fragments in a single run. Over 45% of the world's total sequencing capacity was now dedicated to precision oncology workflows, which was a clear indication of the Next Generation Sequencing Market Trend towards personalized medicine. The progress in long-read sequencing, AI-powered analysis pipelines, and automation has also helped to speed up lab productivity, thus making Next Generation Sequencing Market at the core of current genomic research and clinical ‍‌‍‍‌‍‌‍‍‌decision-making.

By‍‌‍‍‌‍‌‍‍‌ 2024, North America Next Generation Sequencing Market, with more than 400 genomic labs, robust government funding, and early clinical adoption of sequencing-based tests, was the major market to utilize Next Generation Sequencing. After North America, Europe Next Generation Sequencing also played a significant role through considerable investment in population-scale genome projects co-funded and co-operated by the UK, Germany, and Nordic countries, and sequencing of more than 5 million individuals collectively. The Asia-Pacific Next Generation Sequencing Market was the most rapidly growing hub and together with China and Japan, they were responsible for more than 30% of the global sequencing output as a result of an aggressive public–private genomic infrastructure expansion. At the same time, India’s genomic testing volume increased by more than 25% mainly since of the growing demand for oncology and reproductive health ‍‌‍‍‌‍‌‍‍‌diagnostics.

The‍‌‍‍‌‍‌‍‍‌ main factor that progressed the Next Generation Sequencing Industry along in 2024 was the number of diagnostic tests, especially since clinical Next Generation Sequencing tests ran the show globally with over 50 million tests throughout the year. Besides that, pharmaceutical R&D was another major source of demand, as more than 70% of drug discovery programs used sequencing-based biomarker analysis in Next Generation Sequencing Industry. Reduced sequencing costs per genome was still under $300 for simple workflows had made it possible for markets that were previously less accessible to acquire the technology. The rise in the use of liquid biopsy had the main driver of this growth, whereby Next Generation Sequencing-based circulating tumor DNA tests had increased by more than 35%. On a different note, agriculture and microbial genomics had contributed to more than 12% of the total sequencing activities, which was a clear indication of the cross-industry adoption of this ‍‌‍‍‌‍‌‍‍‌technology.

This extensive analysis by Jadhavar Business Intelligence Pvt Ltd provides consumers with a complete and actionable picture of the Global Next Generation Sequencing Market, including market size, share, trends, and growth estimates from 2024 to 2030. It provides a complete overview of important locations and countries by Product Type, Technology, Application and End-User. Clients receive comprehensive market dynamics, business tool analysis (PORTER and PESTLE), a Technology roadmap, and regulatory updates. The study also includes country-specific projections, competitive benchmarking, Company profiles, and M&A activity, all of which aid in strategic planning, market entry analysis, and competitor positioning in Next Generation Sequencing Industry.

Next Generation Sequencing Market Dynamic’s

The‍‌‍‍‌‍‌‍‍‌ primary factor that led to the growth of the Next Generation Sequencing Market in 2024 was the rapid movement of the industry towards clinical genomics. The volume of sequencing-based diagnostic tests has been reported to have gone up by more than 40% year-on-year across the three fields of oncology, genetic screening, and infectious diseases. The increased number of decentralized sequencing labs, which has now exceeded 3,000 active clinical Next Generation Sequencing facilities globally, had the main driver behind this growth. A higher number of AI-driven variant interpretations has led to a reduction of up to 60% in the time of the analysis, thus, clinical workflow efficiency had improved. In addition, over 200 novel Next Generation Sequencing based assays had granted regulatory clearances globally, thus, sequencing technologies became the preferred choice of institutional investors had the ‍‌‍‍‌‍‌‍‍‌outcome.

Although‍‌‍‍‌‍‌‍‍‌ the Next Generation Sequencing Market has grown rapidly; it has been threatened with various challenges. High operational costs were the most significant of these challenges, as advanced sequencing workflows still needed USD 1-2 million of lab infrastructure spending per year. Data complexity was the main obstacle, as more than 55% of clinical laboratories reported that their bioinformatics capacity was insufficient to handle the increasing volume of data. The turnaround time for the completion of the tests was very different, especially in low-resource areas, and that was why the clinical reporting was delayed for up to 8-10 days. Moreover, difficult regulatory pathways and limited reimbursement coverage had delayed the uptake of products, particularly in healthcare systems that was still ‍‌‍‍‌‍‌‍‍‌developing.

The‍‌‍‍‌‍‌‍‍‌ Next Generation Sequencing Market was full of opportunity, due to the increasing clinical utility, the numerous genome initiatives globally, and the rapid technological breakthroughs. Population-scale sequencing programs was covering more than 20 million individuals globally had created new possibilities for pharmacogenomics and large-cohort disease research. Emerging Next Generation Sequencing Market had a gasp of fresh air as a 30% increase in decentralized sequencing capacity allowed a more general use of oncology and reproductive genomics. The technology improvements, such as ultra-rapid sequencing resulting in run times below 2 hours and cloud-native analytics that reduce storage costs by 40%, made accessibility even more attractive. There was also a significant increase in the number of strategic collaborations between diagnostic companies and pharma companies, with over 150 partnerships was announced throughout the ‍‌‍‍‌‍‌‍‍‌year.

Expert Insight:

Next Generation Sequencing Market is rapidly shifting into mainstream clinical use, powered by falling costs, AI-driven analysis, and strong adoption in oncology and genetic testing, though challenges like high infrastructure needs and bioinformatics gaps still limit full-scale global deployment.

Next Generation Sequencing Market Segment Analysis

The Next Generation Sequencing Market is segmented into Product Type, Technology, Application and End-User.

By Technology

Based on Technology segment the Next Generation Sequencing Market is segmented into Whole Genome Sequencing, Targeted Sequencing & Re-sequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing and Methyl Sequencing. Targeted Sequencing & Re-sequencing has the largest market share of Next Generation Sequencing Market, accounted for 42.5% in 2024. This dominance was driven by its wide clinical adoption, economical nature, and capability of providing focused, high-depth insights which were vital for oncology, inherited disease testing, and infectious disease analysis. Targeted panels need 70-80% less sequencing volume than whole genome workflows, thus, they were quicker, more cost-effective, and have a simpler data interpretation. The growing utilization of them in standard diagnostics, as a result of regulatory-approved panels and solid reimbursement coverage, has definitively targeted sequencing as the leading technology of ‍‌‍‍‌‍‌‍‍‌2024.

By Application

Based on Application Segment, the Next Generation Sequencing Market is segmented into Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases, Agricultural & Animal Research and Others. Within the Application segment, Diagnostics/Infectious Diseases appears the dominated sub segment have market share, accounted for 48% in 2024 for Next Generation Sequencing Market. This dominance driven by Sequencing-based‍‌‍‍‌‍‌‍‍‌ tests for oncology diagnostics, hereditary disease detection, and pathogen surveillance were the main clinical applications that rapidly adopted the tests. The number of clinical Next Generation Sequencing tests increased very fast as a result of the demand for liquid biopsies, rapid pathogen identification, and companion diagnostics supporting targeted therapies. This segment was preferred by hospitals and reference labs because Next Generation Sequencing-enabled diagnostics are more sensitive, faster in turnaround, and provide richer genomic insights, thus making it the most widely utilized application ‍‌‍‍‌‍‌‍‍‌globally.

Next Generation Sequencing Market Region Analysis

In‍‌‍‍‌‍‌‍‍‌ 2024, the North America Next Generation Sequencing Market dominated global market accounted for 45.60% of market share. This market dominance was mainly owing to the strong clinical adoption of sequencing-based diagnostics in the region, a large number of advanced genomic labs, and the early use of Next Generation Sequencing in the testing of oncology and reproductive health. The U.S. Next Generation Sequencing Industry carried out more than 20 million clinical Next Generation Sequencing tests in the year, which was made possible by the establishment of favourable reimbursement routes and significant investments in precision medicine programs. Besides the presence of major Next Generation Sequencing industry players and strong academic research networks, and the continuous FDA approvals, North America Next Generation Sequencing Market became the most mature and innovation-led market globally and hence, the region solidified its ‍‌‍‍‌‍‌‍‍‌position.

Europe‍‌‍‍‌‍‌‍‍‌ Next Generation Sequencing Market was the second-largest market and was mainly supported by national genome programs and the global adoption of diagnostics in oncology and rare diseases. The total sequencing volume of this market increased by more than 18%, with the UK and Germany was the main contributors to the demand. The Asia-Pacific Next Generation Sequencing Market was the fastest-growing market, a Next Generation Sequencing Market trend mainly influenced by China, Japan, and South Korea, which jointly accounted for over 30% of the global sequencing output as a result of the rapid growth of infrastructure and the availability of low-cost sequencing services. Latin America Next Generation Sequencing Market and the Middle East Next Generation Sequencing Market had shown some potential as a result of the increased adoption of tertiary-care hospitals and a rise in genomic research investments. However, adoption has mainly concentrated in the major urban ‍‌‍‍‌‍‌‍‍‌centers.

Next Generation Sequencing Market Competitive Analysis

Illumina Inc, Thermo Fisher Scientific,Inc, and F. Hoffmann-La Roche Ltd. This trio was at the forefront of the Next Generation Sequencing Industry, and together they had the most significant impact on the global Next Generation Sequencing ecosystem. Illumina remained on top because of its long sequencing platform portfolio, which accounted for more than 65% of the installations of Next Generation Sequencing instruments globally, and was backed by a solid substance ecosystem and data accuracy that was difficult to match. The company Thermo Fisher achieved and kept a good position by providing affordable Ion Torrent systems and a wide clinical adoption in oncology and infectious disease labs. With its strong diagnostics footprint and a growing portfolio of Next Generation Sequencing based assays, Roche continued to be a major player in the clinical genomics field and solidified its ‍‌‍‍‌‍‌‍‍‌dominance.

After‍‌‍‍‌‍‌‍‍‌ the top players, these companies had a major influence to evolve the Next Generation Sequencing Industry in various ways. PacBio, Oxford Nanopore, and 10x Genomics differentiated themselves competitively by innovating in long-read, nanopore, and single-cell sequencing technologies respectively. BGI Genomics positioned itself as a volume-centric service provider. Eurofins and Novogene were the major contributors in spreading sequencing services globally through their extensive laboratory networks. Agilent, QIAGEN, and NEB were instrumental in strengthening the integration of sample prep, library kits, and analysis tools across Next Generation Sequencing workflows. On the other hand, Danaher and Merck KGaA used their life-science portfolios to provide the most needed reagents and instrumentation, thus, they were among the major contributors to a diversified, innovation-driven competitive ‍‌‍‍‌‍‌‍‍‌landscape.

Next Generation Sequencing Market Scope:

Next Generation Sequencing Market Key Players –

Illumina, Inc.
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd. (Roche)
QIAGEN N.V.
Agilent Technologies, Inc.
Pacific Biosciences (PacBio)
Oxford Nanopore Technologies
BGI Genomics / BGI Group
PerkinElmer, Inc.
Eurofins Scientific
Danaher Corporation
Merck KGaA
10x Genomics
New England Biolabs (NEB)
Novogene Co., Ltd.

Frequently Ask Questions –

1) Who are the major Key players of Next Generation Sequencing Market?

Ans - The Major Key players of Next Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd. (Roche QIAGEN N.V. and Agilent Technologies, Inc.

2) Which Region accounted highest share of the Next Generation Sequencing Market in 2024?

Ans – North America region accounted highest share of the Next Generation Sequencing Market.

3) What was the market size of Next Generation Sequencing Market in 2024?

Ans – In 2024, market size of the Next Generation Sequencing Market is USD 10.30 Billion.

4) Which Segment is expected to lead the market during forecast period?

Ans – Technology Segment was the top segment holds the largest share in Next Generation Sequencing Market during forecast period.

5) What will be the market size of Next Generation Sequencing Market in 2030?

Ans- The market size of Next Generation Sequencing Market in 2030 will be USD 24.07 Billion.

Report Payment

Single User:

$4199

Spreadsheet:

$2900

Corporate User:

$5500

Buy Now

Download Report Sample

Request for Customization

Speak with Analyst